- Home
- EDIT vs PRPL Comparison
EDIT vs PRPL Comparison
Compare EDIT & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- PRPL
- Stock Information
- Founded
- EDIT 2013
- PRPL 2010
- Country
- EDIT United States
- PRPL United States
- Employees
- EDIT N/A
- PRPL N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- PRPL Home Furnishings
- Sector
- EDIT Health Care
- PRPL Consumer Discretionary
- Exchange
- EDIT Nasdaq
- PRPL Nasdaq
- Market Cap
- EDIT 108.1M
- PRPL 96.8M
- IPO Year
- EDIT 2016
- PRPL N/A
- Fundamental
- Price
- EDIT $1.25
- PRPL $0.75
- Analyst Decision
- EDIT Buy
- PRPL Hold
- Analyst Count
- EDIT 14
- PRPL 2
- Target Price
- EDIT $8.08
- PRPL $1.25
- AVG Volume (30 Days)
- EDIT 2.5M
- PRPL 1.4M
- Earning Date
- EDIT 03-05-2025
- PRPL 03-13-2025
- Dividend Yield
- EDIT N/A
- PRPL N/A
- EPS Growth
- EDIT N/A
- PRPL N/A
- EPS
- EDIT N/A
- PRPL N/A
- Revenue
- EDIT $32,314,000.00
- PRPL $487,877,000.00
- Revenue This Year
- EDIT N/A
- PRPL $3.96
- Revenue Next Year
- EDIT N/A
- PRPL $8.16
- P/E Ratio
- EDIT N/A
- PRPL N/A
- Revenue Growth
- EDIT N/A
- PRPL N/A
- 52 Week Low
- EDIT $1.12
- PRPL $0.65
- 52 Week High
- EDIT $7.41
- PRPL $2.12
- Technical
- Relative Strength Index (RSI)
- EDIT 41.70
- PRPL 41.31
- Support Level
- EDIT $1.24
- PRPL $0.79
- Resistance Level
- EDIT $1.32
- PRPL $0.90
- Average True Range (ATR)
- EDIT 0.11
- PRPL 0.09
- MACD
- EDIT -0.03
- PRPL 0.00
- Stochastic Oscillator
- EDIT 2.94
- PRPL 27.55
Stock Price Comparison Chart: EDIT vs PRPL
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.